ELITE PHARMACEUTICALS INC /NV/ (ELTP) › Total LiabilitiesELITE PHARMACEUTICALS INC /NV/ (ELTP) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2011: $29.66M2012: $25.30M2013: $19.80M2014: $105.52M2015: $25.65M2016: $20.51M2017: $8.65M2018: $12.41M2019: $13.01M2020: $14.30M2021: $10.04M2022: $9.93M2023: $11.94M2024: $26.07M2025: $42.87M$42.87M2011Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$42.87M+64.4%2024$26.07M+118.4%2023$11.94M+20.2%2022$9.93M-1.1%2021$10.04M-29.8%2020$14.30M+10.0%2019$13.01M+4.8%2018$12.41M+43.5%2017$8.65M-57.8%2016$20.51M-20.0%2015$25.65M-75.7%2014$105.52M+432.9%2013$19.80M-21.7%2012$25.30M-14.7%2011$29.66M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share